Bio-Techne Corporation Return on Capital Employed (ROCE) for the Trailing 12 Months (TTM) ending March 31, 2025: 7.92%

Bio-Techne Corporation Return on Capital Employed (ROCE) is 7.92% for the Trailing 12 Months (TTM) ending March 31, 2025, a -21.89% change year over year. Return on capital employed assesses profitability against invested capital; higher ROCE signals efficient capital use.
  • Bio-Techne Corporation Return on Capital Employed (ROCE) for the Trailing 12 Months (TTM) ending March 31, 2024 was 10.14%, a -16.80% change year over year.
  • Bio-Techne Corporation Return on Capital Employed (ROCE) for the Trailing 12 Months (TTM) ending March 31, 2023 was 12.18%, a 12.46% change year over year.
  • Bio-Techne Corporation Return on Capital Employed (ROCE) for the Trailing 12 Months (TTM) ending March 31, 2022 was 10.83%, a -11.93% change year over year.
  • Bio-Techne Corporation Return on Capital Employed (ROCE) for the Trailing 12 Months (TTM) ending March 31, 2021 was 12.30%, a 56.03% change year over year.
Key Data
Date Return on Capital Employed (ROCE) Return on Equity (ROE) Return on Assets (ROA) Revenue Per Share